Renouf Publishing Co. Ltd.
embedded image
Online Bookstore

Quick Search
Advanced search
Featured books
New in print
Best Sellers
President's picks
Online publications

Shopping cart/Checkout  [0]
Sign-up for eUpdates
European Pharmacopoeia, 11th Main Edition (3-Volumes)
(Includes 11.1 and 11.2 Supplements)
Publication year: 2022

Cdn: $1,195.00; US: $895.00
Language: English
Add to cart
The 11th Edition of the European Pharmacopoeia (EP) main volume and supplements are legally binding and details the qualitative and quantitative composition of medicines, the Tests to be carried out on medicines, on the raw materials used in the production of medicines and on the intermediates of synthesis.

The EP is a single reference work for the quality control of medicines in Europe. All producers of medicines or substances for pharmaceutical use must apply the quality standards of the European Pharmacopoeia for the marketing and use of these products in Europe.

The EP outlines preparations for pharmaceutical use of chemical, animal, human or herbal origin. It also covers biological, blood and plasma derivatives, vaccines and radiopharmaceutical preparations. The monographs give quality standards for all the main medicines used in Europe.

The 11th Edition consists of all the texts published in the 10th Edition, which may subsequently have been revised or corrected, and new texts. The new edition now includes QR codes for easier linking to the Knowledge database and contains a Subscription Key (EPID Code) giving access to the EP’s online archives.

Publication Schedule Published Implemented
EP Main 11th Edition July 2022 January 2023
EP Supplement 11.1 October 2022 April 2023
EP Supplement 11.2 January 2023 July 2023

The EP is a subscription product and all orders must be prepaid. Renouf's price includes the shipping costs to deliver the two supplements.

European Pharmacopoeia, 11th Main Edition (3-Volumes)
Cdn: $1,195.00; US: $895.00
Council of Europe BookID: 129504 Added: 2022.6.22